Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology